Skip to content

Clinical trials

Terminated Phase 3 Cognitive Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 3 Status: Terminated Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20082
20101
20141
20151
20161
20182
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.2
M. Schaefer, MD2
Eisai Co., Ltd.1
Erasmus Medical Center1
Lakshmi N Yatham1
Novartis1
Pfizer1
Sun Yat-sen University1
TauRx Therapeutics Ltd1
The George Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction14
Alzheimer Disease5
Dementia5
Delirium2
Down Syndrome2
Schizophrenia2
Brain Diseases1
Brain Neoplasms1
Breast Neoplasms1
Central Nervous System Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.